Skip to Main Content

Author Details

John Kornak
University of California san francisco
2002
128
41
PMIDPaper TitleJournal TitlePublished Year
36846611Factors Associated With Long COVID Symptoms in an Online Cohort Study.Open Forum Infect Dis2023
37505107Effect of Longitudinal Variation in Tumor Volume Estimation for MRI-guided Personalization of Breast Cancer Neoadjuvant Treatment.Radiol Imaging Cancer2023
37180971Feasibility and acceptability of remote smartphone cognitive testing in frontotemporal dementia research.Alzheimers Dement (Amst)2023
36977552Plasma inflammation for predicting phenotypic conversion and clinical progression of autosomal dominant frontotemporal lobar degeneration.J Neurol Neurosurg Psychiatry2023
37278627Comparison of Mammography AI Algorithms with a Clinical Risk Model for 5-year Breast Cancer Risk Prediction: An Observational Study.Radiology2023
37205649A complex systems model of breast cancer etiology: The Paradigm II Model.PLoS One2023
36591730Multisite ALLFTD study modeling progressive empathy loss from the earliest stages of behavioral variant frontotemporal dementia.Alzheimers Dement2023
34854532The contribution of behavioral features to caregiver burden in FTLD spectrum disorders.Alzheimers Dement2022
35584922Sensitivity of the Social Behavior Observer Checklist to Early Symptoms of Patients With Frontotemporal Dementia.Neurology2022
35349636Proposed research criteria for prodromal behavioural variant frontotemporal dementia.Brain2022
35645385Effect of Inter-Reader Variability on Diffusion-Weighted MRI Apparent Diffusion Coefficient Measurements and Prediction of Pathologic Complete Response for Breast Cancer.Tomography2022
35389890Role of antibodies, inflammatory markers, and echocardiographic findings in postacute cardiopulmonary symptoms after SARS-CoV-2 infection.JCI Insight2022
35448706Post-Processing Bias Field Inhomogeneity Correction for Assessing Background Parenchymal Enhancement on Breast MRI as a Quantitative Marker of Treatment Response.Tomography2022
36523412Factors Associated with Long Covid Symptoms in an Online Cohort Study.medRxiv2022
36139594Diffusion-Weighted MRI for Predicting Pathologic Complete Response in Neoadjuvant Immunotherapy.Cancers (Basel)2022
36030718Detection of emerging neurodegeneration using Bayesian linear mixed-effect modeling.Neuroimage Clin2022
33295938Association of a Proposed New Staging System for Folliculotropic Mycosis Fungoides With Prognostic Variables in a US Cohort.JAMA Dermatol2021
33857770Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementia.Cortex2021
34427465Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response.Radiology2021
33247623Brain volumetric deficits in MAPT mutation carriers: a multisite study.Ann Clin Transl Neurol2021
33215852Development and validation of the Uniform Data Set (v3.0) executive function composite score (UDS3-EF).Alzheimers Dement2021
31272932Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration.Alzheimers Dement2020
31784375Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration.Alzheimers Dement2020
31636026The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodology.Alzheimers Dement2020
31914230Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint.Alzheimers Dement2020
31914218Utility of the global CDR[®] plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium.Alzheimers Dement2020
31914217Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases.Alzheimers Dement2020
33298938Predicting breast cancer response to neoadjuvant treatment using multi-feature MRI: results from the I-SPY 2 TRIAL.NPJ Breast Cancer2020
33318514Evaluation of primary breast cancers using dedicated breast PET and whole-body PET.Sci Rep2020
32803155Predictive Value of Breast MRI Background Parenchymal Enhancement for Neoadjuvant Treatment Response among HER2- Patients.J Breast Imaging2020
32656921Quality of life and caregiver burden in familial frontotemporal lobar degeneration: Analyses of symptomatic and asymptomatic individuals within the LEFFTDS cohort.Alzheimers Dement2020
32591470Longitudinal structural and metabolic changes in frontotemporal dementia.Neurology2020
32548299Tumor Sphericity Predicts Response in Neoadjuvant Chemotherapy for Invasive Breast Cancer.Tomography2020
32548283Impact of MRI Protocol Adherence on Prediction of Pathological Complete Response in the I-SPY 2 Neoadjuvant Breast Cancer Trial.Tomography2020
32371446Revised Self-Monitoring Scale: A potential endpoint for frontotemporal dementia clinical trials.Neurology2020
30698757Longitudinal multimodal imaging and clinical endpoints for frontotemporal dementia clinical trials.Brain2019
31872042Nonlinear Z-score modeling for improved detection of cognitive abnormality.Alzheimers Dement (Amst)2019
31585367Tracking white matter degeneration in asymptomatic and symptomatic MAPT mutation carriers.Neurobiol Aging2019
31175026The costs of dementia subtypes to California Medicare fee-for-service, 2015.Alzheimers Dement2019
31623919Patient-Tailored, Connectivity-Based Forecasts of Spreading Brain Atrophy.Neuron2019
31566651Effect of Collaborative Dementia Care via Telephone and Internet on Quality of Life, Caregiver Well-being, and Health Care Use: The Care Ecosystem Randomized Clinical Trial.JAMA Intern Med2019
31081015Neuropathological correlates of structural and functional imaging biomarkers in 4-repeat tauopathies.Brain2019
31026118Additive value of diffusion-weighted MRI in the I-SPY 2 TRIAL.J Magn Reson Imaging2019
29328531Thalamic atrophy in multiple sclerosis: A magnetic resonance imaging marker of neurodegeneration throughout disease.Ann Neurol2018
30131973Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis.NPJ Breast Cancer2018
30349860Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory.Ann Clin Transl Neurol2018
29616911The Rural Inpatient Mortality Study: Does Urban-Rural County Classification Predict Hospital Mortality in California?Perm J2018
27861836Out-of-Network Emergency Department Use among Managed Medicaid Beneficiaries.Health Serv Res2017
28413716Data-driven regions of interest for longitudinal change in three variants of frontotemporal lobar degeneration.Brain Behav2017
29053860Clinicopathological correlations in behavioural variant frontotemporal dementia.Brain2017
  • 1 - 50 of 128

Recommended Authors

Biocruces Bizkaia Health Research Institute
Career Start Year 2015
Number of shared co-authors 0
Montreal Neurological Institute, McGill University
Career Start Year 2013
Number of shared co-authors 3
The Renaissance School of Medicine at Stony Brook University
Career Start Year 2012
Number of shared co-authors 1
University of Pennsylvania
Career Start Year 2011
Number of shared co-authors 3
University of Pennsylvania
Career Start Year 2011
Number of shared co-authors 11
Johns Hopkins Bloomberg School of Public Health
Career Start Year 2011
Number of shared co-authors 2
Perelman School of Medicine University of Pennsylvania
Career Start Year 2011
Number of shared co-authors 15
University of Copenhagen
Career Start Year 2010
Number of shared co-authors 3
Washington University in St. Louis
Career Start Year 2009
Number of shared co-authors 13
Indiana University School of Medicine
Career Start Year 2009
Number of shared co-authors 44
Harvard Medical School
Career Start Year 2007
Number of shared co-authors 11
University of North Carolina
Career Start Year 2003
Number of shared co-authors 8
Center for Clinical and Translational Science, Mayo Clinic
Career Start Year 2002
Number of shared co-authors 50
Mallinckrodt Institute of Radiology, Washington University School of Medicine
Career Start Year 2002
Number of shared co-authors 32
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 2001
Number of shared co-authors 5
Institute of Biomedical Engineering, Bogazici University
Career Start Year 2000
Number of shared co-authors 1
Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital
Career Start Year 1999
Number of shared co-authors 7
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1998
Number of shared co-authors 22
Haukeland University Hospital
Career Start Year 1997
Number of shared co-authors 32
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1996
Number of shared co-authors 3
University of Iowa
Career Start Year 1995
Number of shared co-authors 2
Institute of Psychiatry, King's College London
Career Start Year 1994
Number of shared co-authors 31
Hospital Israelita Albert Einstein - Sao Paulo
Career Start Year 1994
Number of shared co-authors 1
University of Pennsylvania
Career Start Year 1992
Number of shared co-authors 37
Monash University
Career Start Year 1991
Number of shared co-authors 5
University of Maryland School of Medicine
Career Start Year 1991
Number of shared co-authors 5
Keck School of Medicine of University of Southern California
Career Start Year 1990
Number of shared co-authors 14
Rotman Research Institute
Career Start Year 1984
Number of shared co-authors 15
Harvard Medical School, Massachusetts General Hospital
Career Start Year 1975
Number of shared co-authors 10
University of Oxford
Career Start Year 1970
Number of shared co-authors 25

Collaborators

UCSF Weill Institute for Neurosciences, University of California san francisco
Co-authored papers 36
UCSF Weill Institute for Neurosciences, University of California san francisco
Co-authored papers 36
UCSF Weill Institute for Neurosciences, University of California san francisco
Co-authored papers 30
UCSF Weill Institute for Neurosciences, University of California san francisco
Co-authored papers 29
Mayo Clinic Rochester
Co-authored papers 22
University of California San Francisco
Co-authored papers 21
University of California san francisco
Co-authored papers 19
Keio University School of Medicine
Co-authored papers 18
Mayo Clinic Florida
Co-authored papers 17
Mayo Clinic Rochester
Co-authored papers 16
Weill Institute for Neurosciences, University of California san francisco
Co-authored papers 14
Case Western Reserve University
Co-authored papers 14
University of British Columbia
Co-authored papers 13
David Geffen School of Medicine, University of California los angeles
Co-authored papers 13
Indiana University School of Medicine
Co-authored papers 12
University of Pennsylvania
Co-authored papers 12
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 11
University of Antwerp
Co-authored papers 11
Johns Hopkins University School of Medicine
Co-authored papers 10
Mayo Clinic Rochester
Co-authored papers 10
Co-authored papers 9
Mayo Clinic Rochester
Co-authored papers 9
UCSF Weill Institute for Neurosciences, University of California san francisco
Co-authored papers 9
University of California davis
Co-authored papers 8
Kerwin Research Center and Memory Care Dallas Texas USA.
Co-authored papers 8
Helen Wills Neuroscience Institute, University of California Berkeley
Co-authored papers 8
Mayo Clinic
Co-authored papers 7
University of Southern California
Co-authored papers 7
Evelyn F. McKnight Brain Institute, University of Arizona
Co-authored papers 7
National Institute on Aging
Co-authored papers 6